Medicare Enrolled
Dr. Peter Vaselopulos, MD
Urology Physician · Evanston, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Vaselopulos from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vaselopulos?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Vaselopulos
Dr. Peter Vaselopulos is an urology physician in Evanston, IL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Vaselopulos performed 4,100 Medicare services across 2,054 unique beneficiaries.
Between the years covered by Open Payments, Dr. Vaselopulos received a total of $8,972 from 52 pharmaceutical and/or device companies across 380 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Vaselopulos is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 25% volume in IL
$8,972 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,100
Medicare services
Top 25% in IL for urology physician
2,054
Unique beneficiaries
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~216 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
991 | $8 | $89 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
792 | $66 | $260 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
733 | $91 | $300 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
580 | $66 | $165 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 235 | $131 | $2,000 |
| Endoscopic destruction of bladder/urethra growth, less than 0.5 cm A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters. |
117 | $641 | $4,539 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
96 | $45 | $125 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
92 | $120 | $620 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
88 | $179 | $908 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
66 | $10 | $50 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
55 | $109 | $329 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
52 | $145 | $455 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
47 | $71 | $200 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
35 | $20 | $564 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
33 | $44 | $471 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
24 | $42 | $103 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
21 | $120 | $2,816 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
15 | $113 | $527 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
14 | $269 | $1,619 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
14 | $204 | $985 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.9% high complexity
27.3% medium
71.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,972
Total received (2018-2024)
Avg $1,282/year across 7 years
Top 19% in IL for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
380
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,484 (94.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$489 (5.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,393
2023
$1,486
2022
$1,087
2021
$1,294
2020
$955
2019
$1,455
2018
$1,304
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$446
PROCEPT BioRobotics Corporation
$136
Blue Earth Diagnostics Limited
$131
Sumitomo Pharma America, Inc.
$114
Astellas Pharma US Inc
$69
Laborie Medical Technologies Corp.
$66
ABBVIE INC.
$65
PFIZER INC.
$63
Axonics, Inc.
$47
Phathom Pharmaceuticals, Inc.
$44
Ferring Pharmaceuticals Inc.
$41
Teleflex LLC
$37
Pacira Pharmaceuticals Incorporated
$35
IMMUNITYBIO, INC.
$29
ACCORD HEALTHCARE, INC.
$18
Lilly USA, LLC
$18
180 Medical, Inc.
$17
Myriad Genetic Laboratories, Inc.
$17
Top 3 companies account for 51.2% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$1,856
Astellas Pharma US Inc
$1,427
PFIZER INC.
$906
PROCEPT BioRobotics Corporation
$658
AbbVie, Inc.
$371
Retrophin, Inc.
$334
AbbVie Inc.
$320
Blue Earth Diagnostics Limited
$276
Sumitomo Pharma America, Inc.
$254
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$219
Bayer HealthCare Pharmaceuticals Inc.
$217
ABBVIE INC.
$200
Takeda Pharmaceuticals U.S.A., Inc.
$195
Travere Therapeutics, Inc.
$169
Avadel Specialty Pharmaceuticals, LLC
$128
Teleflex LLC
$126
Janssen Products, LP
$99
Amgen Inc.
$89
Olympus America Inc.
$81
Myovant Sciences Inc.
$78
Axonics, Inc.
$69
Laborie Medical Technologies Corp.
$66
Verity Pharmaceuticals Inc.
$52
Boston Scientific Corporation
$50
Phathom Pharmaceuticals, Inc.
$44
Dendreon Pharmaceuticals LLC
$43
AstraZeneca Pharmaceuticals LP
$43
Medtronic, Inc.
$42
Ferring Pharmaceuticals Inc.
$41
180 Medical, Inc.
$39
TOLMAR Pharmaceuticals, Inc.
$39
Pacira Pharmaceuticals Incorporated
$35
HealthTronics Mobile Solutions, LLC
$32
Myriad Genetic Laboratories, Inc.
$32
Exact Sciences Corporation
$31
Merck Sharp & Dohme Corporation
$30
IMMUNITYBIO, INC.
$29
UROVANT SCIENCES INC
$26
Clarus Therapeutics Inc.
$23
NxThera, Inc.
$19
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$19
ACCORD HEALTHCARE, INC.
$18
Lilly USA, LLC
$18
Accord Healthcare, Inc.
$18
Shire North American Group Inc
$17
AMAG Pharmaceuticals, Inc.
$16
Mission Pharmacal Company
$15
Allergan, Inc.
$15
Synergy Pharmaceuticals Inc
$14
NeoTract Inc.
$14
Hollister Incorporated
$14
Janssen Pharmaceuticals, Inc
$9
Top 3 companies account for 46.7% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AKEEGA · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · Androgel · Axonics · Axumin · BOTOX · Bipolar Disposables · CAMCEVI · Cologuard Collection Kit · ELIGARD · ENTYVIO · ERLEADA · EVENITY · Entyvio · Erleada · Exparel · GATTEX · GEMTESA · GENERAL BPH · GENTLECATH · GENTLECATH GLIDE · General - Kidney Stone Disease · INTERSTIM · INTRAROSA · JATENZO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LifeVest · Lithostat · Lupron · Lupron Depot · MYRBETRIQ · Mobile Cryoblation Services · Myrbetriq · Noctiva · Nubeqa · OMVOH · ORGOVYX · Olympus Accessories · Onli · Optilume BPH Drug Coated Balloon Catheter · POSLUMA · PREMARIN · PROLARIS · PROVENGE · PVC · Prolaris · Prolia · RELISTOR · Rezum · TOVIAZ · Thiola · Trelstar · Trulance · UCERIS TABLETS · UROLIFT · UroLift · VOQUEZNA · XGEVA · XIFAXAN · XIFAXANIBSD · XTANDI · Xofigo · Xtandi · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
317
Per 100K population
6.1
County median income
$81,797
Nearest hospital
SAINT FRANCIS HOSPITAL-EVANSTON
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Vaselopulos is a clinical cardiology specialist, with above-average Medicare volume (top 25% in IL), with low-engagement industry engagement in the top 19% of IL peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Vaselopulos experienced with bladder ultrasound after voiding?
Based on Medicare claims data, Dr. Vaselopulos performed 991 bladder ultrasound after voiding services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vaselopulos receive payments from pharmaceutical companies?
Yes. Dr. Vaselopulos received a total of $8,972 from 52 companies across 380 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vaselopulos's costs compare to other urology physicians in Evanston?
Dr. Vaselopulos's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vaselopulos) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Evanston
Browse urology physicians in Evanston ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in IL
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in IL
Which IL urology physicians receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology